Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity
Open Access
- 1 October 1998
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 115 (4) , 954-966
- https://doi.org/10.1016/s0016-5085(98)70268-9
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Association of Malaria Parasite Population Structure, HLA, and Immunological AntagonismScience, 1998
- Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitopeEuropean Journal of Immunology, 1997
- Apoptosis by Death FactorCell, 1997
- Antagonists or altruists: do viral mutants modulate T-cell responses?Immunology Today, 1995
- Variability of hepatitis C virusHepatology, 1995
- Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.Journal of Clinical Investigation, 1995
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Journal of Clinical Investigation, 1995
- Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in LymphotoxinScience, 1994
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Rearrangements of Genes for the Antigen Receptor on T Cells as Markers of Lineage and Clonality in Human Lymphoid NeoplasmsNew England Journal of Medicine, 1985